Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem for you to read. Along with our medical data and news we also list Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem Clinical Trials, which are updated daily. BioPortfolio also has a large database of Influenza Vaccination At A Reduced Dose Using Mesotherapy In HIV/AIDS Patients At The Hadassah AIDS Center, Jerusalem Companies for you to search.
Inventiva Announces Results From Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis Primary endpoint of the trial was not met, no statistically significant difference between the placebo and lanifibranor treated groups for the primary outcome Favorable safety profile of lanifibranor observed Decision to discontinue further developments in the treatment of ...
The congress will focus on key clinical topics in the management of genitourinary malignancies Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host the 2019 New York GU™: 12th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies meeting on March 15 and 16 ...
Fast-Casual Brand Adds Plant-Based Burger to the Burger Bar Lineup Muscle Maker Grill, the fast-casual restaurant brand, which promotes a healthy lifestyle by offering nutritious alternatives to traditional dishes, today announced the addition of the plant-based Impossible Burger, which delivers unprecedented taste, nutrition and versatility com...
Allogeneic CAR-Ts could serve an important niche – particularly for patients who can’t receive autologous CAR-Ts – but the earliness of the data makes conclusions tough to draw.
Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers might object to helping fund treatment, which at the time cost hundreds of thousands of dollars, for patients in their twilig...
Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar ... Read More
GPs should resist requests from patients to issue longer repeat prescriptions in the run up to Brexit and should liaise closely with pharmacists if they are concerned about shortages of specific...
Over 80% of Hong Kong people consider participating Near 40% of respondents underestimate the medical expenses AXA Hong Kong expands healthcare plan coverage to meet market needs HONG KONG, Feb. 18, 2019 /PRNewswire/ -- The Hong Kong public health care system is at the brink of saturation, coupled with the se...
Prof Funda Meric-Bernstam speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about a study looking at the combination of CB-839 with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer. She explains that...
Theresa Shao, MD, discusses the neoadjuvant and adjuvant findings with pertuzumab as well as the adjuvant use of neratinib in patients with locally advanced HER2-positive breast cancer.
Quantzig, a leading analytics advisory firm that delivers customized analytics solutions, has announced the completion of their free supplement on the roadmap to healthcare analytics. Amidst the skyrocketing healthcare costs, companies in the
Prof Evan Yu speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about Cohort A of the KEYNOTE-365 study which looked at the combination of pembrolizumab plus olaparib in docetaxel-pretreated patients with metastatic castrate-resistant...
Patients are now able to apply online for an instant digital prescription prepayment certificate (PPC) following a successful national pilot.
DUBLIN–(BUSINESS WIRE)–The “Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends” report has been added to ResearchAndMarkets.com’s offering. CAR-T cell therapy is a remarkably promising treatment for cancer patients. This emerging treatment represents one of the biggest … Continue reading →
(MedPage Today) -- Also, how to prevent unplanned hospitalization for cancer patients
Vizient today announced its support for the Advancing Care for Exceptional (ACE) Kids Act. The bipartisan ACE Kids Act would expand care options and promote enhanced care coordination for children who have complex medical needs. In letters to the lead sponsors in the House and Senate, Vizient has offered our formal endorsement of the ACE Kids Act. ...
Sarah B. Goldberg, MD, MPH, sheds light on the complex treatment paradigm for patients with lung cancer who have central nervous system metastases and highlights emerging treatment strategies for those with mesothelioma.
EchoNous, an innovator focused on delivering intelligent medical tools, announces the release of EchoNous Bladder™, a highly reliable, all-electronic, non-mechanical, bladder scanning tool for nurses. To help nurses quickly determine bladder volume of patients, EchoNous Bladder combines data-rich fanning, a state-of-the-
Laura J. Esserman, MD, MBA, a 2018 Giants of Cancer Care® award winner in the Cancer Diagnostics category led the way in designing the I-SPY clinical trials, a groundbreaking effort to match patients with breast cancer to potential therapies based on molecular drivers of disease. She also has advocated for a greater understanding of the biological drivers of breast cancer, rather than relying ...
Researchers have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the early diagnosis of the cardiotoxicity associated with this group of widely used chemotherapy drugs.